Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04194528 · ClinicalTrials.gov registry record · NA
S1916 Digital Medicine Program for Pain Control in Cancer Patients
A NA study, sponsored by SWOG Cancer Research Network.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT04194528 is a NA study that was terminated before completion, run by SWOG Cancer Research Network. The registered enrollment target is 2 participants.
The verdict
NCT04194528, a NA study, was terminated before completion, sponsored by SWOG Cancer Research Network.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
This is a feasibility study to assess the use of a Digital Medicine Program (consisting of an FDA-approved ingestible sensor co-encapsulated with oxycodone/acetaminophen (5 mg/325 mg), a small wearable patch, and a mobile application) in cancer patients with metastatic disease experiencing uncontrolled pain.
Interventions
- DRUG Oxycodone/acetaminophen 5/325 mg
- DEVICE Proteus digital medicine program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2020-01-22 |
| Est. Completion | 2020-09-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04194528
The ClinicalTrials.gov registry entry for NCT04194528 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is SWOG Cancer Research Network, which has 270 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Oxycodone/acetaminophen 5/325 mg is the first listed.
NCT04194528 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04194528 about?
NCT04194528 is a clinical study titled "S1916 Digital Medicine Program for Pain Control in Cancer Patients". This is a feasibility study to assess the use of a Digital Medicine Program (consisting of an FDA-approved ingestible sensor co-encapsulated with oxycodone/acetaminophen (5 mg/325 mg), a small wearable patch, and a mobile application) in cancer patients with metastatic disease experiencing uncontrol...
What is the current status of trial NCT04194528?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2020-01-22. Estimated completion is 2020-09-16.
What interventions are being tested in trial NCT04194528?
The interventions under investigation include: Oxycodone/acetaminophen 5/325 mg (DRUG), Proteus digital medicine program (DEVICE).
Who is sponsoring clinical trial NCT04194528?
This trial is sponsored by SWOG Cancer Research Network, which has 270 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.